Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate: A Key Intermediate for Fexuprazan Synthesis
Your trusted source for advanced pharmaceutical intermediates, driving innovation in GERD treatment.
Get a Quote & SampleProduct Core Value
Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate
This specialized compound serves as a critical building block in the pharmaceutical industry, particularly in the development of Fexuprazan, a novel therapeutic agent targeting gastroesophageal reflux disease (GERD). Its precise chemical structure and high purity make it indispensable for reliable drug development and manufacturing processes.
- Explore the critical role of this methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate in fexuprazan intermediate synthesis for advanced pharmaceutical applications.
- Discover the wide range of CAS 1902955-29-6 applications in cutting-edge drug development and innovative chemical synthesis.
- Learn about the importance of pharmaceutical intermediate development in creating effective treatments for conditions like GERD.
- Understand how custom synthesis of pharmaceutical intermediates ensures the quality and efficacy of final drug products.
Advantages This Product Offers
Unlocking GERD Treatment Potential
As a key fexuprazan intermediate, this compound significantly contributes to the advancement of treatments for gastroesophageal reflux disease, offering a pathway to new therapeutic solutions.
Driving Chemical Synthesis Innovation
Leverage this methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate for innovative chemical synthesis, ensuring high yields and purity in your research and production.
Ensuring Pharmaceutical Quality
The development of advanced pharmaceutical intermediates like this is paramount for maintaining the highest quality standards in drug manufacturing, ensuring patient safety and treatment effectiveness.
Key Applications
Pharmaceutical Synthesis
Utilize this compound as a vital building block in the complex pharmaceutical synthesis pathways, ensuring the efficient creation of active pharmaceutical ingredients.
GERD Treatment Research
Its direct role as a fexuprazan intermediate makes it essential for researchers investigating novel approaches to treating gastroesophageal reflux disease.
Drug Development Pipeline
Integrate this intermediate into your drug development pipeline to accelerate the journey from discovery to market for new medications.
Custom Chemical Solutions
Benefit from custom synthesis services to tailor the production of this intermediate to your specific project requirements and timelines.